​
​

Spyre Therapeutics (SYRE) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Spyre Therapeutics Revenue Highlights

Latest Revenue (Y)

$886.00K

0

Spyre Therapeutics Revenue by Period

Spyre Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$886.00K-61.96%
2022-12-31$2.33M-87.57%
2021-12-31$18.74M100.00%
2020-12-31--

Spyre Therapeutics generated $886.00K in revenue during NA 2023, up -61.96% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Spyre Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$1.04M100.00%
2023-09-30--100.00%
2023-06-30$688.00K247.47%
2023-03-31$198.00K17.86%
2022-12-31$168.00K-3.45%
2022-09-30$174.00K-72.16%
2022-06-30$625.00K-54.11%
2022-03-31$1.36M-62.62%
2021-12-31$3.64M160.47%
2021-09-30$1.40M-89.79%
2021-06-30$13.70M-

Spyre Therapeutics generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Spyre Therapeutics Revenue Breakdown

Spyre Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23
License-

SYRE Revenue FAQ

What is Spyre Therapeutics’s yearly revenue?

Spyre Therapeutics's yearly revenue for 2023 was $886K, representing a decrease of -61.96% compared to 2022. The company's yearly revenue for 2022 was $2.33M, representing a decrease of -87.57% compared to 2021. SYRE's yearly revenue for 2021 was $18.74M, representing an increase of 100.00% compared to 2020.

What is Spyre Therapeutics’s quarterly revenue?

Spyre Therapeutics's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). SYRE's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a -100.00% decrease year-over-year (Q1 2023).

What is Spyre Therapeutics’s revenue growth rate?

Spyre Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -95.27%